ClinicalTrials.Veeva

Menu

Investigation of Heylo, a Novel App Driven Digital Supporting Ostomy Product

Coloplast logo

Coloplast

Status

Completed

Conditions

Ileostomy - Stoma
Colostomy Stoma

Treatments

Device: Standard of Care
Device: Heylo

Study type

Interventional

Funder types

Industry

Identifiers

Details and patient eligibility

About

People with intestinal stomas can have, despite development of better ostomy products, problems with leakage which influence their quality of life negatively.

To overcome this, Coloplast has developed a new supporting ostomy product called Heylo™, which has an adhesive sensor layer that should be placed underneath the baseplate. The sensor layer consists of an electronic sensor system that continuously detects moisture and output leakage underneath the baseplate. A transmitter connected to the sensor layer continuously evaluates the incoming information and sends a status to a smartphone software application, which based on a predefined flow decides which information to deliver to the user about the baseplate status.

The overall aim of this clinical investigation is to evaluate the benefits of the new supporting product, Heylo compared to Standard of Care.

Full description

The Investigational device - Heylo, is already CE-marked.

The investigation is an open-labelled, randomized cross-over trial with two test periods evaluating Heylo and Standard of Care.

In total 144 subjects having an ileostomy or an colostomy will be included and randomized.

Enrollment

144 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Has given written consent to participate by signing the Informed Consent Signature Form.
  • Is at least 18 years of age and has full legal capacity.
  • Has an ileostomy or colostomy with consistent liquid/mushy fecal output (5-7 Bristol scale*)
  • Is able to use one of the five test products (i.e. Ø40, Ø50, Ø60, Ø70, Ø80 mm).
  • Has experienced leakage** under the baseplate at least three times within the last fourteen days. **Leakage defined as output seeping under the baseplate"
  • Has worry about leakage to "some degree, high degree, or very high degree" (on a five-point Likert scale: Very low degree/Not at all, Low degree, some degree, High degree, very high degree)
  • Is willing to refrain from use of ostomy paste.
  • Has a smartphone compatible with the Heylo™ application
  • Is able to follow study procedures for 4 months (assessed by investigator or delegate)

Exclusion criteria

  • Is participating in other clinical investigations or has previously participated in this investigation
  • Is pregnant or breastfeeding
  • Has known hypersensitivity towards any of the products used in the investigation
  • Is using/ has a pacemaker

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

144 participants in 2 patient groups

Test Product - Heylo
Experimental group
Description:
The arm includes the test product Heylo
Treatment:
Device: Heylo
Device: Standard of Care
Standard of Care
Active Comparator group
Description:
The arm includes Standard of Care
Treatment:
Device: Heylo
Device: Standard of Care

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems